Cover Image
市場調查報告書

Achillion Pharmaceuticals, Inc. - 產品平台分析

Achillion Pharmaceuticals, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 224621
出版日期 內容資訊 英文 47 Pages
訂單完成後即時交付
價格
Back to Top
Achillion Pharmaceuticals, Inc. - 產品平台分析 Achillion Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日期: 2015年04月30日 內容資訊: 英文 47 Pages
簡介

Achillion Pharmaceuticals, Inc.是研發、開發對付 傳染病用創新治療法,之後並將之商品化的生物製藥企業。尤其致力於抗病毒劑及抗菌藥效類別,以及慢性C型肝炎及抗藥性細菌感染症的治療藥開發。

本報告提供Achillion Pharmaceuticals, Inc.的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥的評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Achillion Pharmaceuticals, Inc.的基本資料

Achillion Pharmaceuticals, Inc.概要

  • 主要資訊
  • 企業資料

Achillion Pharmaceuticals, Inc.:R&D概要

  • 主要的治療範圍

Achillion Pharmaceuticals, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Achillion Pharmaceuticals, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Achillion Pharmaceuticals, Inc.:藥物簡介

  • dACH-3102
  • deldeprevir
  • ACH-3080
  • ACH-3107
  • ACH-3422
  • Small Molecule to Inhibit Topoisomerase for Bacterial Infections
  • Small Molecules to Inhibit DNA Gyrase for Bacterial Infections

Achillion Pharmaceuticals, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Achillion Pharmaceuticals, Inc.:最近的開發平台趨勢

Achillion Pharmaceuticals, Inc.:暫停中的計劃

Achillion Pharmaceuticals, Inc.:開發中止的開發中產品

  • 開發中止的開發中產品簡介
    • ACH-2928

Achillion Pharmaceuticals, Inc.:企業發表

Achillion Pharmaceuticals, Inc.:總公司和子公司的所地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07006CDB

Summary

Global Markets Direct's, 'Achillion Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Achillion Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Achillion Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Achillion Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Achillion Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Achillion Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Achillion Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Achillion Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Achillion Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Achillion Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Achillion Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Achillion Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Achillion Pharmaceuticals, Inc. Snapshot
    • Achillion Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Achillion Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Achillion Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Achillion Pharmaceuticals, Inc. - Pipeline Products Glance
    • Achillion Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Achillion Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Achillion Pharmaceuticals, Inc. - Drug Profiles
    • ACH-3102
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • sovaprevir
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ACH-3422
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • deldeprevir
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ACH-3080
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ACH-3107
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ACH-CFDIS
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit DNA gyrase for Bacterial Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Immunology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Complement Factor D for Acute Hemolytic Uremic Syndrome
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Complement Factor D for AMD
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Complement Factor D for Myasthenia Gravis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit DNA gyrase for Bacterial Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Achillion Pharmaceuticals, Inc. - Pipeline Analysis
    • Achillion Pharmaceuticals, Inc. - Pipeline Products by Target
    • Achillion Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
    • Achillion Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Achillion Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Achillion Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Achillion Pharmaceuticals, Inc. - Dormant Projects
  • Achillion Pharmaceuticals, Inc. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • ACH-2928
  • Achillion Pharmaceuticals, Inc. - Company Statement
  • Achillion Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Achillion Pharmaceuticals, Inc., Key Information
  • Achillion Pharmaceuticals, Inc., Key Facts
  • Achillion Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Achillion Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Achillion Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Achillion Pharmaceuticals, Inc. - Phase II, 2015
  • Achillion Pharmaceuticals, Inc. - Phase I, 2015
  • Achillion Pharmaceuticals, Inc. - Preclinical, 2015
  • Achillion Pharmaceuticals, Inc. - Discovery, 2015
  • Achillion Pharmaceuticals, Inc. - Pipeline by Target, 2015
  • Achillion Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
  • Achillion Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Achillion Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Achillion Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
  • Achillion Pharmaceuticals, Inc. - Dormant Developmental Projects,2015
  • Achillion Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2015

List of Figures

  • Achillion Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
  • Achillion Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Achillion Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Achillion Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015
  • Achillion Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Achillion Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Achillion Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top